He described strong free cash flow and returning $78 million to shareholders through repurchases and dividends in the quarter.

Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer – – Expects to report ...

Saudi Arabia’s NEOM, the Public Investment Fund’s flagship development, is accelerating work as the Oxagon industrial city ...

The official launching of the Emsaad–Ras Ajdair Highway project took place in Tripoli, following the signing of a contract ...

U.S. truck engine maker Cummins on Thursday reported third-quarter results above Wall Street estimates, driven by strong ...

Widening motorways will help tackle traffic in short-term, with long-term push to bolster public transport crucial ...